China SXT Pharmaceuticals, Inc. (SXTC) |
| 2.352 0.032 (1.38%) 04-14 12:56 |
| Open: | 2.33 |
| High: | 2.41 |
| Low: | 2.32 |
| Volume: | 4,444 |
| Market Cap: | 2(M) |
| PE Ratio: | -0.04 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 3.01 |
| Resistance 1: | 2.58 |
| Pivot price: | 1.84 |
| Support 1: | 1.76 |
| Support 2: | 1.25 |
| 52w High: | 1047 |
| 52w Low: | 1.25 |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
| EPS | -8340000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | -14.080 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 11.7 |
| Return on Equity (ttm) | -18.3 |
Thu, 09 Apr 2026
China SXT Pharmaceuticals announces $760,000 share offering on Monday By Investing.com - Investing.com Australia
Thu, 09 Apr 2026
China SXT Pharmaceuticals announces $760,000 share offering on Monday - Investing.com
Thu, 09 Apr 2026
SXTC (NASDAQ: SXTC) sells 2M Class A shares at $0.38 for $760K - Stock Titan
Thu, 09 Apr 2026
China SXT (SXTC) raises about $760K in 2M-share stock offering - Stock Titan
Mon, 23 Mar 2026
China SXT gives new Class B shares 50 votes each in reclassification - Stock Titan
Mon, 23 Mar 2026
China SXT Pharmaceuticals, Inc. Announces Share Re-classification - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |